At the IGTP TODAY
PATH2XNAT is a collaborative effort that merges the capabilities of 3 European research infrastructures: Euro-BioImaging, ELIXIR, and EATRIS through a consortium comprised by the following partners: Germans Trias i Pujol Research Institute (IGTP), EMC and Charité Universitätsmedizin Berlin.
The activity of Èpica Foundation La Fura dels Baus, co-financed by the Spanish Foundation for Science and Technology (FECYT), in collaboration with Germans Trias i Pujol Research Institute (IGTP), Institute of Biomedical Research of Barcelona (IIBB-CSIC), Polytechnic University of Catalonia, and Computer Vision Center (CVC-UAB), took place from 14 to 26 May at Casa de l'Aigua (Trinitat Nova) in Barcelona. The results were presented last weekend before more than 200 people.
Dr Sofía España, a researcher from the Cancer Mechanisms and Pathways Group at IGTP and the Badalona Applied Research Group in Oncology (B·ARGO) IGTP-Institut Català d'Oncologia (ICO), has been awarded one of the prestigious Clínico Junior Grants by the Spanish Association Against Cancer. This grant will enable her to balance her clinical duties with research, focusing on the development of a minimally invasive diagnostic tool to classify different types of colorectal cancer, advancing towards precision medicine.
The collaborative action DATOS-CAT aims to enhance the visibility and scientific impact of population-based cohorts created in Catalonia. Additionally, it seeks to enrich the procedures used in these cohorts, promoting their applicability in other similar contexts. To achieve this, it focuses on improving data interoperability, thereby facilitating their exploitation and use in scientific research.
On 21 March, the final meeting of INNOVA4TB, a consortium led by IGTP with researchers from around the world, took place. Participants presented the results of the different work packages and evaluated the work done since 2019. IGTP will continue to be involved in other networks such as ADVANCE-TB and SMA-TB.
The Innomed programme has been launched with the ambition of transforming the landscape of health innovation at the Can Ruti Campus, creating synergies between the public and private sectors. With a structured approach around three key axes - nurturing the culture of innovation, fostering project incubation, and facilitating cross-sector collaboration - Innomed aims to turn knowledge into action to achieve tangible impact on the healthcare community.
To better understand the complexity of P. vivax infections, the CaixaResearch project "Novel organ-on-a-chip technology to study extracellular vesicles-mediated cryptic infections in Plasmodium vivax malaria" has produced this video to disseminate key insights into cryptic erythrocytic infections. The initiative is led by Hernando A del Portillo and Carmen Fernandez-Becerra, group leaders of the Plasmodium vivax and Exosome Research Group (PvREX) at the Barcelona Institute for Global Health (ISGlobal) and the Germans Trias i Pujol Research Institute (IGTP) in Spain.
Two studies by CEEISCAT with the PISCIS cohort show that people living with HIV have been less vaccinated with the full initial regimen against COVID-19
The European Union's project THRIVE held its kick-off meeting on 12 January 2024 in Barcelona. The project is coordinated by Josep M. Llovet (IDIBAPS). IGTP collaborates as a partner through c-LOG, led by Carolina Armengol.
Research teams from BSC-CNS, UPV/EHU and IGTP are working on a project that uses artificial intelligence to predict and prevent type 2 diabetes. This initiative is part of the Complementary Plan for Biotechnology Applied to Health, coordinated by IBEC.
